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Abstract
Background: Acute mesenteric ischemia is a rare affection with high related mortality. NOMI presents the most
important diagnostic problems and is related with the higher risk of white laparotomy. This study wants to give a
contribution for the validation of laparoscopic approach in case of NOMI.
Methods: Thirty-two consecutive patients were admitted in last 10 years in ICU of Paolo Giaccone University
Hospital of Palermo for AMI. Diagnosis was obtained by multislice CT and selective angiography was done if clinical
conditions were permissive. If necrosis was already present or suspected, surgical approach was done. Endovascular
or surgical embolectomy was performed when necessary. Twenty NOMI patients underwent medical treatment
performing laparoscopy 24 h later to verify the evolution of AMI. A three-port technique was used. In all patients
we performed a bed side procedure 48–72 h later in both non-resected and resected group.
Results: In 14 up 20 case of NOMI the disease was extended throughout the splanchnic district, in 6 patients it
involved the ileum and the colon; after a first look, only 6 patients underwent resection. One patient died 35 h after
diagnosis of NOMI. The second look, 48 h later, demonstrated 4 infarction recurrences in the group of resected
patients and onset signs of necrosis in 5 patients of non-resected group. A total of 15 resections were performed
on 11 patients. Mortality rate was 6/20–30% but it was much higher in resected group (5/11–45,5%). Non-
therapeutic laparotomy was avoided in 9/20 patients and in this group mortality rate was 1/9–11%. No morbidity
was recorded related to laparoscopic procedure.
Conclusions: Laparoscopy could be a feasible and safety surgical approach for management of patient with NOMI.
Our retrospective study demonstrates that laparoscopy don’t increase morbidity, reduce mortality avoiding non-
therapeutic laparotomy.
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Background
Acute mesenteric ischemia is a rare affection with high
related mortality. It accounts 1:1000 acute hospital admis-
sions in Europe and the USA [1] and presents a very high
mortality with a range from 50 to 69% [2–5] of cases.
The affection consists in an acute arterial occlusion
due to embolism (EAMI), or thrombosis (TAMI), in a
venous thrombosis (VAMI) or, at last, in an non-
occlusive mesenteric ischemia (NOMI).
Pathophysiology is different in each type as risk fac-
tors. Different are also comorbidities and clinical find-
ings. In all cases diagnosis is very difficult because there
aren’t specific laboratory tests.
EAMI is often related to hearth disease (atrial fibrilla-
tion, myocardial infarction, etc.) and causes acute symp-
toms as diarrhoea, vomiting, acute abdominal pain;
TAMI is characterized by more indolent onset with
post-prandial pain and weight loss in patients with his-
tory of atherosclerosis, hypertension, diabetes; VAMI
occurs in 10% of cases in patients with hypercoagulable
disorders, malignancies, hepatitis, pancreatitis, and other
affections causing slow blood flow. NOMI occurs mostly
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in critically ill patients with hypovolemia, hypotension,
recent treatment with beta blockers or alpha adrenergic.
Usually these are patients with endotracheal tube and
symptoms can start in acute or gradual way.
Nowadays the gold standard for diagnosis is CT, which
offers a good accuracy in AMI detection with high values
of sensitivity and specificity [6], but it is well known that
these values are not similar in each etiological type.
NOMI is an exclusion diagnosis. It presents the most
important diagnostic problems due to lack of specific
radiological features on CT, which usually shows a
normal bowel wall and a high variability of its contrast
enhancement ranging from absent or diminished to in-
creased [7]. So, in the suspicious of NOMI an anamnesis
of low arterial flow or low cardiac output (recent cardiac
failure, prolonged cardio-pulmonary resuscitation, car-
diac surgery, severe cardiac failure, aortic dissection and
aneurism, recent aortic vascular surgery etc..), biochem-
ical findings (>TGO/>TGP;> LDL, >CPK, >Bilirubin),
signs of Acute Kidney Failure (altered level of creatinine,
urea and electrolytes, reduced urine output). When
possible a selective angiography or an angio-CT should
be performed [8] to confirm diagnosis, exclude other
form of AMI and to start the medical treatment (fluid
infusion, prostaglandins, etc.) (Fig. 1).
Then NOMI needs a very close follow-up to obtain an
early detection of mesenteric infarction which imposes
bowel resection. Early diagnosis and prompt interven-
tion are the goals of modern treatment. It can stop the
fatal progression of sepsis that is responsible of the high
mortality rate [9].
Also, the treatment is different in each type of AMI
[10]: resolution of embolism in open surgery (especially
if bowel necrosis is present) or in endovascular way is
the choice treatment in patients with EAMI or TAMI.
In case of VAMI the first choice is anticoagulation and
finally in patients with NOMI the first step is the infu-
sion of fluids and vasodilators; the last mentioned are
administered directly via Superior Mesenteric Artery
(SMA) when possible. If bowel necrosis is present,
resection is necessary at the same time [10].
Although CT consents a differential diagnosis in pa-
tients with doubtful abdominal presentation and for
these reason is the first diagnostic step for these patient,
there isn’t any diagnostic test which can early indicate
the onset of bowel necrosis. The aim of this study is to
show our results of systematic use of laparoscopy in
bowel infarction detection in critical ill patients.
Methods
A retrospective study was carried out on 32 consecutive
patients recovered in last 10 years (1st January 2006–31st
December 2015) in ICU of Paolo Giaccone University
Hospital of Palermo. The patients’ age, clinical symptoms,
biochemistry and radiological findings were considered.
In all patients, AMI was diagnosed by multislice CT
(Fig. 2); selective angiography was done if clinical condi-
tions were permissive.
If necrosis was already present or suspected, surgical
approach was done. Moreover, endovascular or surgical
embolectomy was performed in cases with EAMI or
TAMI whilst VAMI and NOMI patients underwent
Fig. 1 Procedural Algorithm in case of NOMI in ICU
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medical treatment performing laparoscopy 24 h later to
verify the evolution of AMI.
A three-port technique was used [11, 12]: a 10-mm
camera-port was positioned through the umbilical scar.
After a first exploration of the abdomen, other two
5 mm operative-trocars were put in the left hypochon-
drium and in the left iliac fossa. In this way, as in right
laparoscopic colectomy, an accurate exploration of entire
small bowel was possible starting from the ileocecal
junction and going back up to the Treitz ligament.
Colon was entirely explored. Only in 4 patients a fourth
5 mm port in right flank was needed.
The bowel aspect and the ischemia extension were
evaluated; all patients showed widespread intestinal
pallor therefore, the first suffering loop was searched
(intense pallor, necrosis signs) and the necrotic bowel was
resected when present. The involved bowel was mobilized
and after vessels ligation it was externalized through a 5–
6 cm laparotomy. After resection, no anastomosis was
done and an ostomy was performed. The absence of signs
of necrosis is not to be underestimated because of the
rapid precipitation of NOMI clinical features.
Therefore, in all patient medical therapy was contin-
ued and EBPM was administered using prophylactic dos-
ages, the procedure was repeated 48–72 h later (Second
Look) in both non-resected and resected group, looking
for new necrotic areas.
Due the organization of our Hospital in nearly but
separated departments, a bed-side laparoscopy was per-
formed to avoid the transfer of the critically ill patients
to the department of radiology or to operation room
that often can leads to serious difficulties especially
when the transfers are multiple. A laparoscopic column
and a centralized CO2 distribution system are available
in ICU and allow the execution of bed side laparoscopy.
The availability of mobilizable beds in ICU support the
surgeon to perform explorative laparoscopy with low
Co2 flow and pressure (8–10 mmHg). Only two sur-
geons need to perform the procedure and the second or
further looks are performed through the same sites used
before. A 10-mm optic and two laparoscopic forceps or
an ultrasound dissector allow the exploration and the
dissection of bowel needs resection (Table 1). In case of
re-resection the bowel was extracted trough the same
previous incision and after a distal ligation of vessels,
resection was performed with linear stapler. Moreover,
in all cases ostomy and mucous fistula was is performed.
Safety and efficacy of the procedure was evaluated in
terms of mortality, diagnosed infarctions and avoided
non-therapeutic laparotomy. Postoperative morbidity
was an outcome not reliable due to multiple comorbidity
already present in our patients.
Results
Among 32 critical ill patients with CT report of AMI, 6
presented EAMI, 3 TAMI, 1 VAMI and 20 NOMI
(Table 2).
Main biochemical and CT findings of NOMI patients
are collected in Table 3. In all NOMI cases (20) an in-
tense pallor of bowel wall was the main laparoscopic
finding. In 14 cases, it was extended throughout the
splanchnic district, whilst in 6 patients it involved mainly
the ileum and the colon (right colon 2 cases; left colon 3
cases; entire colon 1 case); every patient in last group
underwent resection to prevent bowel necrosis and peri-
tonitis in 5 cases, whilst in 1 patient bowel resection was
Fig 2 Angio-CT, a case of NOMI: Radiologic Science
Department–AOUP Palermo
Table 1 Necessary equipment for bed-side laparoscopy
Laparoscopic Column including: CO2 insufflator, HD camera, light
source, HD monitor
Optic 10 mm
N° 2 laparoscopic forceps
Ultrasound dissector with disposable device
N° 3 Trocars (10 mm, 5 mm, 5 mm)
Surgical drapes
Basic Surgical Kit
Table 2 ICU patients with AMI
ICU patients with AMI (1st January 2006–31 December 2015)
Type of AMI N° of cases
EAMI 6
TAMI 3
VAMI 1
NOMI 20
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necessary to remove a necrotic segment. After a first look
only 6 patients underwent bowel resection and its exten-
sion was since 15 up to 175 cm. After resection in each
patient a stoma and a mucous fistula were performed on
the proximal and the distal stump respectively (Table 4).
Only one non-resected patient died 35 h after diagnosis
of NOMI and before the second look for cardiac failure.
The second look, 48 h later, demonstrated 4 infarction
recurrences in the group of resected patients and the on-
set of necrosis in 5 patients of non-resected group. A total
of 15 resections were performed on 11 patients (Table 5).
Table 3 Laboratory and CT findings
Patients Age GOT (U/L)
nv: 0–31
GPT (U/L)
nv: 0–31
LDH (U/L)
nv: 240–480
CPK (U/L)
nv: 26–192
CREATININE mg/dl
nv: 0,51–0,95
WBC vn 4–11
10^3 uL
CT FINDINGS
1 66 520 489 3125 1223 5.1 26,28 negative for SMA obstruction, bowel
infarction, peritoneal collections
2 79 610 498 1225 251 1,3 22,3 negative for SMA obstruction, paralytic
ileum signs
3 75 426 286 1316 680 1,4 23,6 negative for SMA obstruction, paralytic
ileum signs
4 54 838 778 1198 889 1,3 24,68 negative for SMA obstruction, right colon
and ileum thickening
5 81 650 568 2218 1001 3,2 17,42 negative for SMA obstruction, diffuse colon
and bowel infarction, peritoneal collections
6 82 466 598 1589 996 1,9 15,69 negative for SMA obstruction, paralytic
ileum signs
7 61 835 687 1286 754 1,75 22,65 negative for SMA obstruction, right colon
and ileum thickening
8 90 589 410 1857 1028 2,6 14,8 negative for SMA obstruction, left colon
and ileum thickening
9 78 380 520 1635 987 2,4 15,1 negative for SMA obstruction, peritoneal
collections
10 76 489 475 856 385 1,9 23,2 negative for SMA obstruction, bowel
infarction
11 71 554 598 758 235 2,4 20,1 negative for SMA obstruction, bowel
infarction, peritoneal collections
12 61 665 689 1105 624 1,4 18,7 negative for SMA obstruction, paralytic
ileum signs
13 78 811 799 658 201 1,2 14,8 negative for SMA obstruction, bowel
infarction
14 69 715 684 2890 1425 3,3 18,4 negative for SMA obstruction, left colon
and ileum thickening
15 82 542 396 1687 1215 2,7 17,5 negative for SMA obstruction, paralytic
ileum signs
16 69 496 389 1420 893 2,6 18,84 negative for SMA obstruction, bowel
infarction, peritoneal collections
17 78 675 497 752 358 1,5 26,3 negative for SMA obstruction, paralytic
ileum signs
18 87 742 694 3869 1845 4,8 24.3 negative for SMA obstruction, left colon
and ileum thickening
19 78 868 688 1012 854 2,7 16,4 negative for SMA obstruction, paralytic
ileum signs
20 72 308 258 1536 1088 3,7 37,26 negative for SMA obstruction, peritoneal
collections
Table 4 Extension of ischemic tract in NOMI patients
Extension of Ischemia In NOMI patients
Bowel site N° of cases 1st look resection cases
Small Bowel and other splancnic
organs
14 0
Ileum and right colon 2 2
Left colon 3 3
Entire colon 1 1
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Mortality rate was 6/20 (30%) but it was much higher in
resected group (5/11–45,5%). Non-therapeutic laparotomy
was avoided in 9/20 patients (45%) and in this group mor-
tality rate was 1/9 (11,1%). No morbidity was recorded re-
lated to laparoscopic procedure (Tables 6 and 7).
Discussion
NOMI is an infrequent type of AMI and accounts 20%
of cases. It is more frequent in critically ill patients and
depends on combination of two distinct factors; low
cardiac output and vasoconstrictive agents.
In literature, there are no high evidences about clinical
findings, diagnosis and therapy of AMI and even less
about NOMI. It is possible to found some case-series
recording the experience of single centres and in this
way, the present report is a contribution about diagnos-
tic and therapeutic pathway in critically ill patients with
suspicious NOMI.
It is well known that decreased mortality for AMI in
last years is related to more aggressive therapeutic
approach in occlusive shapes like surgical or non-
surgical blood flow restoration, resection of necrotic
bowel, supportive intensive care. Moreover, the precocity
of the treatment is highly related with its success.
But if in patients with occlusive forms the operative
(surgical or not-surgical) approach ever follows diagnosis
of AMI, in NOMI patients the treatment consists of
pharmacological therapy with the need of continuous
monitoring of ischemia. Only the onset of necrosis will
require surgery. Because of the absence of tests that
consent a determination of further bowel viability, lapar-
oscopy can represent a diagnostic technique with high
potential therapeutic options. We used it in NOMI
patients both at the first and the second look to detect
and remove dead bowel avoiding certain general and
access-related risks associated with laparotomy [13].
Moreover, it is well known how the surgical stress could
be life-threatening in these patients, and so to avoid a
non-therapeutic laparotomy could be a very important
step in their clinical course.
In our centre, it was started 10 years ago, routinely use
of laparoscopy in critical ill patients presenting clinical
and radiological findings suggesting AMI. Laparoscopy
was utilized like the last diagnostic procedure and the
first therapeutic step.
Explorative laparoscopy allowed to avoid 9/20 (45%)
non-therapeutic laparotomies and at the same time it
showed in 11 cases the presence of bowel necrosis; In 6
patients at the first look and in 9 patients at the second
look. Four of second look resected patients had been
already resected at the first look. The routinely execu-
tion of the second look 48 h after the first exploration of
the abdomen is strongly suggested because of patho-
physiology of NOMI [14]. The possible occurrence of
low cardiac output due to surgical procedures (i.e. blood
loss, ECC, etc.), in fact, can cause bowel ischemia but
only in a variable percentage of cases necrosis will occur.
Then in our experience laparoscopy was positively
used in patients with CT-scan diagnosed NOMI both for
the first and the second look to detect the eventual onset
of bowel necrosis. Its advantages were the possibility of
bed-side performing without the surgical stress of
laparotomic access.
Conclusions
NOMI represents a frequent type of AMI diagnosis. CT
scan represent the golden standard in diagnosis of AMI but
has a lower power in defining NOMI forms. Laparoscopy
could be a feasible and safety surgical approach for diagno-
sis of ischaemic tract of bowel and to removing it. Our
retrospective study demonstrate that laparoscopy don’t
increase morbidity and reduce mortality probably avoiding
non-therapeutic laparotomy.
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